CD248, Human (Ontuxizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD248, Human (Ontuxizumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD248, Human (Ontuxizumab biosimilar)
CloneOntuxizumab
Host SpeciesRecombinant Mouse
Reactive Specieshuman
IsotypeIgG1 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsNeut, ELISA, IF, IP, FuncS, FCM, ICC
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD248 Recombinant Antibody. Ontuxizumab is a humanized rabbit monoclonal antibody designed for the treatment of cancer. It binds to endosialin (TEM1 or CD248). Phase I trials are complete and the drug was granted orphan drug status by the FDA for sarcoma. It is currently in phase II trials for melanoma, colorectal cancer, sarcoma, and lymphoma. This drug was developed by Morphotek and Ludwig Institute for Cancer Research.
Immunogenn/a
Other NamesAnti-CD248 Recombinant Antibody, Research Grade Ontuxizumab, Anti-Human CD248 Recombinant Antibody, MORAb-004, Antibody Drug Analogues, Monoclonal Antibody, YR1332, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 946415-62-9
Catalog #YR1332
Priceplease inquire
Order / More InfoCD248, Human (Ontuxizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.